CME GROUP ($CME) posted quarterly earnings results for Q2 2026 on Wednesday, July 22nd. The company reported earnings of $2.99 per share, beating estimates of $2.94 by $0.05. The company also reported revenue of $1,706,200,000, beating estimates of $1,702,277,139 by $3,922,861.
You can see Quiver Quantitative's $CME stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CME GROUP Insider Trading Activity
CME GROUP insiders have traded $CME stock on the open market 13 times in the past 6 months. Of those trades, 4 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:
- TERRENCE A DUFFY (Chairman and CEO) has made 0 purchases and 2 sales selling 35,000 shares for an estimated $10,447,865.
- HILDA HARRIS PIELL (Sr MD & Chief HR Officer) sold 5,753 shares for an estimated $1,752,536
- KEN VROMAN (Chief Transformation Officer) sold 5,160 shares for an estimated $1,594,440
- BRYAN T DURKIN sold 4,200 shares for an estimated $1,300,530
- JONATHAN L MARCUS (Sr MD General Counsel) sold 3,291 shares for an estimated $1,097,120
- WILLIAM R SHEPARD has made 4 purchases buying 1,808 shares for an estimated $515,287 and 0 sales.
- ELIZABETH A COOK sold 1,000 shares for an estimated $320,000
- DENNIS SUSKIND sold 748 shares for an estimated $224,400
- MARTIN J GEPSMAN sold 300 shares for an estimated $91,770
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
CME GROUP Hedge Fund Activity
We have seen 768 institutional investors add shares of CME GROUP stock to their portfolio, and 744 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALPHABET INC. added 3,484,020 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,041,547,779
- CAPITAL RESEARCH GLOBAL INVESTORS added 2,272,083 shares (+213.9%) to their portfolio in Q1 2026, for an estimated $679,239,212
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,074,465 shares (-30.1%) from their portfolio in Q1 2026, for an estimated $620,161,311
- EGERTON CAPITAL (UK) LLP removed 1,182,907 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $261,221,352
- BANK OF AMERICA CORP /DE/ added 1,130,587 shares (+39.1%) to their portfolio in Q1 2026, for an estimated $337,988,983
- TWO SIGMA INVESTMENTS, LP added 1,111,993 shares (+2817.7%) to their portfolio in Q1 2026, for an estimated $332,430,307
- MORGAN STANLEY added 1,043,692 shares (+12.5%) to their portfolio in Q1 2026, for an estimated $312,011,723
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CME GROUP Congressional Stock Trading
Members of Congress have traded $CME stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 06/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
CME GROUP Price Targets
Multiple analysts have issued price targets for $CME recently. We have seen 10 analysts offer price targets for $CME in the last 6 months, with a median target of $312.5.
Here are some recent targets:
- Benjamin Budish from Barclays set a target price of $270.0 on 07/09/2026
- Alex Kramm from UBS set a target price of $260.0 on 07/06/2026
- Patrick O'Shaughnessy from Raymond James set a target price of $320.0 on 07/02/2026
- Chris Allen from Keefe, Bruyette & Woods set a target price of $305.0 on 06/18/2026
- Simon Clinch from Rothschild & Co set a target price of $323.0 on 06/11/2026
- Michael Cyprys from Morgan Stanley set a target price of $353.0 on 04/23/2026
- Patrick Moley from Piper Sandler set a target price of $329.0 on 04/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
